title: RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
authors.forename: Dennis C
authors.initials: DC
authors.lastname: Sgroi
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Haber
authors.forename: Paula D
authors.initials: PD
authors.lastname: Ryan
authors.forename: Xiao-Jun
authors.initials: XJ
authors.lastname: Ma
authors.forename: Mark G
authors.initials: MG
authors.lastname: Erlander
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000235:genetics*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism; D013629:Tamoxifen / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D013629:Tamoxifen